Yoshida Naoki, Kanno Atsushi, Masamune Atsushi, Nabeshima Tatsuhide, Hongo Seiji, Miura Shin, Takikawa Tetsuya, Hamada Shin, Kikuta Kazuhiro, Kume Kiyoshi, Ueno Masamichi, Shimosegawa Tooru
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan.
Division of Internal Medicine, Tohoku Medical and Pharmaceutical University Wakabayashi Hospital, Japan.
Intern Med. 2018 Dec 15;57(24):3529-3535. doi: 10.2169/internalmedicine.0294-17. Epub 2018 Aug 10.
A 79-year-old woman was referred for pancreatic tail cancer with multiple liver metastases. The pancreatic tail tumor was diagnosed as acinar cell carcinoma (ACC) histologically by endoscopic ultrasound-guided fine-needle aspiration. Because of multiple liver metastases, S-1 chemotherapy was administered, resulting in a partial response to chemotherapy one year later. After approximately three years, liver atrophy and esophageal varices developed. We suspected S-1 as the cause of the liver cirrhosis. S-1 cessation minimized ascites and improved the esophageal varices. Although S-1 can potentially treat ACC, we should be watchful for liver cirrhosis caused by its long-term administration.
一名79岁女性因胰尾癌伴多发肝转移前来就诊。通过内镜超声引导下细针穿刺活检,组织学诊断胰尾肿瘤为腺泡细胞癌(ACC)。由于存在多发肝转移,给予S-1化疗,一年后化疗取得部分缓解。大约三年后,出现肝脏萎缩和食管静脉曲张。我们怀疑S-1是肝硬化的病因。停用S-1后腹水减少,食管静脉曲张改善。虽然S-1可能对ACC有治疗作用,但我们应警惕其长期使用导致的肝硬化。